HkRP3 Inhibitors
HkRP3 Inhibitors encompass a variety of chemical compounds that, through their action on diverse biochemical and cellular pathways, indirectly inhibit the functional activity of the protein HkRP3. PPARα agonists like WY-14643 and GW7647 function by enhancing the breakdown of fatty acids, a process which may reduce the pool of lipid substrates integral to HkRP3's role in the cell, particularly if HkRP3 is involved in lipid-mediated signaling or membrane-associated processes. The reduction in available lipids could impede signaling pathways or structural integrity that HkRP3 relies on, thereby inhibiting its activity.
Other compounds act by modulating kinase and phosphatase activity, which is essential for the regulation of many proteins, including HkRP3. Genistein, by inhibiting tyrosine kinases, and PD98059, by targeting the MAPK/ERK pathway, may decrease phosphorylation events that are crucial for HkRP3 function or its regulatory mechanisms.Furthermore, kinase inhibitors like Genistein and PD98059 affect phosphorylation states within the cell. Genistein, known to inhibit tyrosine kinases, could disrupt signaling pathways that are essential for the function of HkRP3. Similarly, PD98059, which inhibits the MAPK/ERK pathway, may reduce the phosphorylation of proteins that regulate or interact with HkRP3.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
A PPARα agonist that enhances fatty acid catabolism. HkRP3, being associated with cellular cytoskeletal organization, could be influenced by changes in lipid metabolism. Enhanced fatty acid catabolism may reduce lipid-mediated signaling or structural components essential for HkRP3's function, leading to its functional inhibition. | ||||||
GW 7647 | 265129-71-3 | sc-203068A sc-203068 sc-203068B sc-203068C | 1 mg 5 mg 10 mg 25 mg | $49.00 $170.00 $267.00 $661.00 | 6 | |
Similar to WY-14643, as a PPARα agonist, GW7647 promotes the breakdown of fatty acids. By doing so, it can indirectly lower the availability of lipids necessary for HkRP3-related processes, diminishing the protein's activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
An inhibitor of tyrosine kinases that could alter phosphorylation states within the cell. If HkRP3 function is dependent on tyrosine kinase signaling, Genistein could impair this signaling, thereby inhibiting HkRP3's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
By inhibiting the MAPK/ERK pathway, PD98059 may decrease the phosphorylation of proteins that interact with or regulate HkRP3, thus indirectly leading to its functional inhibition. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that could impede the AKT signaling pathway. Since AKT can modulate various cellular processes including those involving the cytoskeleton, LY294002's action may result in the indirect inhibition of HkRP3 by altering its cytoskeletal associations. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, Wortmannin, would have a similar effect as LY294002, potentially attenuating the pathways that regulate or interact with HkRP3, leading to its functional inhibition. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 may inhibit stress-activated signaling pathways. If HkRP3 is regulated by such pathways, its activity would be reduced by SP600125. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 MAPK, SB203580 could suppress inflammatory responses or other cellular stress responses that might be necessary for the optimal function of HkRP3. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An AKT inhibitor that could prevent AKT-mediated signaling processes, potentially affecting those that influence HkRP3's activity, resulting in its inhibition. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
An anthelmintic that disrupts Wnt/β-catenin signaling and mitochondrial function. By affecting these pathways, Niclosamide can lead to alterations in cellular signaling and energy metabolism, which could impinge on HkRP3's role in the cell. | ||||||